Cite
HARVARD Citation
Suh, D. et al. (2013). Efficacy and Safety of Pegylated Interferon-α2A in Patients with Lamivudine-Resistant Hbeag-Positive Chronic Hepatitis B. Antiviral therapy. 18 (6), pp. 765-774. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Suh, D. et al. (2013). Efficacy and Safety of Pegylated Interferon-α2A in Patients with Lamivudine-Resistant Hbeag-Positive Chronic Hepatitis B. Antiviral therapy. 18 (6), pp. 765-774. [Online].